Marco Brugia

机构：Azienda Ospedaliero-Universitaria Careggi, University of Florence · ORCID：0000-0001-9389-5146

发表论文 57 篇 · 总被引 673 次 · h-index 15

代表论文

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO (2022 · Journal of Clinical Oncology · 被引 79)
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single‐center experience with 31 patients (2012 · International Journal of Urology · 被引 49)
Results of the observational prospective RealFLOT study (2021 · BMC Cancer · 被引 47)
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives (2021 · Cancers · 被引 46)
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study (2021 · British Journal of Cancer · 被引 43)
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy (2021 · Endocrine · 被引 40)